Aclarion Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Public

  • Employees
  • 6

Employees

  • Stock Symbol
  • ACON

Stock Symbol

  • Share Price
  • $7.33
  • (As of Wednesday Closing)

Aclarion General Information

Description

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

Contact Information

Website
www.aclarion.com
Formerly Known As
Nocimed Inc, Nocimed Inc.
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 8181 Arista Place
  • Suite 100
  • Broomfield, CO 80021
  • United States
+1 (833)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Stock Exchange
NAS
Vertical(s)
SaaS, TMT, HealthTech
Corporate Office
  • 8181 Arista Place
  • Suite 100
  • Broomfield, CO 80021
  • United States
+1 (833)

Aclarion Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aclarion Stock Performance

As of 18-Jun-2025, Aclarion’s stock price is $7.33. Its current market cap is $4.27M with 582K shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$7.33 $7.35 $6.20 - $3.5K $4.27M 582K 45.5K -$67.7M

Aclarion Financials Summary

As of 31-Mar-2025, Aclarion has a trailing 12-month revenue of $54.6K.

In Thousands,
USD 		TTM 31-Mar-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 4,974 191 2,447 1,877
Revenue 55 46 75 60
EBITDA (6,229) (6,265) (4,141) (5,420)
Net Income (6,631) (6,993) (4,911) (7,069)
Total Assets 16,480 2,123 2,460 2,915
Total Debt 1 0 1,126 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Aclarion Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aclarion‘s full profile, request access.

Request a free trial

Aclarion Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore Aclarion‘s full profile, request access.

Request a free trial

Aclarion Patents

  • 90

    Total Documents Applications and Grants

  • Total Patents Families

  • 69

    Granted

  • 13

    Pending

  • Expiring in next 12 mo

Aclarion Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230140742-A1 System for machine learning-based model training and prediction for evaluation of pain Pending 29-Oct-2021
EP-4422486-A1 System for machine learning-based model training and prediction for evaluation of pain Pending 29-Oct-2021
AU-2022378640-A1 System for machine learning-based model training and prediction for evaluation of pain Pending 29-Oct-2021
US-11564619-B2 Magnetic resonance spectroscopy system and method for diagnosing pain or infection associated with propionic acid Active 19-Jun-2016
US-20190307393-A1 Magnetic resonance spectroscopy system and method for diagnosing pain or infection associated with propionic acid Active 19-Jun-2016 A61B5/055
To view Aclarion’s complete patent history, request access »

Aclarion Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aclarion FAQs

  • When was Aclarion founded?

    Aclarion was founded in 2008.

  • Where is Aclarion headquartered?

    Aclarion is headquartered in Broomfield, CO.

  • What is the size of Aclarion?

    Aclarion has 6 total employees.

  • What industry is Aclarion in?

    Aclarion’s primary industry is Diagnostic Equipment.

  • Is Aclarion a private or public company?

    Aclarion is a Public company.

  • What is Aclarion’s stock symbol?

    The ticker symbol for Aclarion is ACON.

  • What is the current stock price of Aclarion?

    As of 18-Jun-2025 the stock price of Aclarion is $7.33.

  • What is the current market cap of Aclarion?

    The current market capitalization of Aclarion is $4.27M.

  • What is Aclarion’s current revenue?

    The trailing twelve month revenue for Aclarion is $54.6K.

  • What is Aclarion’s annual earnings per share (EPS)?

    Aclarion’s EPS for 12 months was -$67.7M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »